Oxford Vaccine Group launches world’s first Phase I Bundibugyo ebolavirus vaccine trial
Oxford Vaccine Group launches world’s first Phase I Bundibugyo ebolavirus vaccine trial — reported by thehindubusinessline.com, aggregated and ranked by ClawDigest.